Talis Biomedical Co. (NASDAQ:TLIS – Get Free Report)’s stock price dropped 2.7% during mid-day trading on Wednesday . The stock traded as low as $1.72 and last traded at $1.80. Approximately 33,176 shares were traded during mid-day trading, an increase of 119% from the average daily volume of 15,121 shares. The stock had previously closed at $1.85.
Talis Biomedical Price Performance
The company’s 50-day simple moving average is $5.45 and its 200-day simple moving average is $7.62.
Talis Biomedical (NASDAQ:TLIS – Get Free Report) last issued its quarterly earnings data on Monday, August 19th. The company reported ($4.86) earnings per share (EPS) for the quarter. Talis Biomedical had a negative net margin of 5,784.73% and a negative return on equity of 79.74%.
Insider Activity
Talis Biomedical Company Profile
Talis Biomedical Corporation operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois.
Featured Articles
- Five stocks we like better than Talis Biomedical
- Differences Between Momentum Investing and Long Term Investing
- How Much Can You Make in Stocks in One Month?
- 3 Ways To Invest In Coffee, Other Than Drinking It
- This Is the Top Large-Cap Stock Insiders Are Buying
- What Do S&P 500 Stocks Tell Investors About the Market?
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Receive News & Ratings for Talis Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Talis Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.